Brief: Exicure Inc Announces Results Of Internal Investigation

Exicure

10/12/2021 22:34

Dec 10 (Reuters) - Exicure Inc  XCUR.O :
    * EXICURE, INC. ANNOUNCES RESULTS OF INTERNAL INVESTIGATION
AND
IMPLEMENTATION OF STRATEGIC MEASURES TO REDUCE CASH BURN AND
PRIORITIZE PIPELINE FOCUS
    * EXICURE INC - WILL REDUCE ITS WORKFORCE BY APPROXIMATELY
50%,
ALONG WITH THE IMPLEMENTATION OF OTHER COST-CUTTING MEASURES
    * EXICURE INC -  BRIAN C. BOCK APPOINTED PRESIDENT AND CHIEF
EXECUTIVE OFFICER
    * EXICURE INC - TO WIND DOWN IMMUNO-ONCOLOGY PROGRAM
CAVROTOLIMOD
(AST-008) AND XCUR-FXN PRECLINICAL PROGRAM
    * EXICURE INC -  EXPECTS TO REALIZE ABOUT $6.0 MILLION IN
EMPLOYEE
RELATED COST SAVINGS IN 2022
    * EXICURE INC -  WILL ALIGN RESEARCH AND DEVELOPMENT
RESOURCES TO
SUPPORT DEVELOPMENT OF ITS PRECLINICAL PROGRAMS TARGETING SCN9A
FOR PAIN AS WELL AS ITS PARTNERED PROGRAMS

Further company coverage:  XCUR.O